- Subjects with arterial hypertension treated with one or more antihypertensive agents,
the doses of which have been stable for at least 4 weeks prior to the baseline visit,
with a documented clinical diagnosis of ED and a confirmation of this by a
qualification of 21 or less on the SHI-M.
- Subjects with resting sitting systolic blood pressure >170 or sitting diastolic blood pressure >90 or disease and retinitis pigmentosa, treatment with nitrates, alfablockers or CYP3A4